tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Fulgent Genetics Inc

FLGT
Add to Watchlist
21.550USD
+0.280+1.32%
Close 09-24 16:00（ET）
612.02MMarket Cap
LossP/E TTM

Fulgent Genetics Inc

21.550
+0.280+1.32%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

FLGT Financials

See Fulgent Genetics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
612.02M
Dividend TTM
0.00
P/E TTM
-9.01
EPS TTM
-2.40
Revenue
322.67M
Net Profit
-42.71M
ROE
-6.78%
ROA
-6.35%

Fulgent Genetics Inc Earnings Date

Latest Release
Jul 30, 2026
EPS / Forecast
-1.05/-0.46
Revenue / Forecast
85.39M/94.00M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-69.89%-1.05
-114.97%-0.80
-293.51%-0.76
55.38%-0.21
-114.47%-0.62
17.31%-0.37
95.54%-0.19
-10.28%-0.48
23.17%-0.29
12.93%-0.45
-435.03%-4.30
---0.44
---0.38
---0.52
---0.80
----
----
----
----
----
Revenue
4.38%85.39M
-3.16%71.14M
9.34%83.34M
17.18%84.07M
15.17%81.80M
13.92%73.46M
8.10%76.21M
-15.28%71.74M
4.68%71.03M
-2.54%64.48M
4.14%70.50M
-19.85%84.69M
-45.87%67.85M
-79.34%66.17M
-73.10%67.70M
-53.63%105.66M
-18.41%125.34M
-10.90%320.27M
-14.68%251.67M
124.02%227.87M
Net Profit
-55.77%-29.53M
-115.32%-24.83M
-297.72%-23.42M
54.89%-6.61M
-117.65%-18.96M
14.35%-11.53M
95.41%-5.89M
-11.76%-14.65M
22.43%-8.71M
12.24%-13.46M
-437.72%-128.15M
-862.48%-13.11M
-197.33%-11.23M
-109.96%-15.34M
-122.84%-23.83M
-98.60%1.72M
-85.54%11.54M
-23.28%153.98M
-37.26%104.34M
162.71%122.52M
Net Margin
-47.85%-34.80%
-119.35%-35.53%
-249.42%-28.38%
60.36%-8.12%
-83.93%-23.54%
24.56%-16.20%
95.74%-8.12%
-28.81%-20.48%
25.08%-12.80%
10.36%-21.47%
-435.79%-190.53%
---15.90%
---17.08%
---23.95%
---35.56%
----
----
----
----
----
Gross Margin
-31.86%27.02%
-23.76%27.35%
-6.41%36.67%
15.33%39.83%
14.98%39.66%
15.02%35.88%
18.69%39.18%
-22.80%34.54%
25.77%34.49%
22.54%31.19%
103.58%33.01%
--44.74%
--27.43%
--25.45%
--16.21%
----
----
----
----
----
Debt to assets ratio
49.32%0.37%
-23.95%0.19%
-23.32%0.23%
123.65%0.24%
111.96%0.25%
97.54%0.25%
-32.40%0.30%
-66.65%0.11%
-74.17%0.12%
-92.37%0.13%
-77.03%0.44%
--0.32%
--0.45%
--1.68%
--1.93%
----
----
----
----
----
Income Statement
Revenue
4.38%85.39M
-3.16%71.14M
9.34%83.34M
17.18%84.07M
15.17%81.80M
13.92%73.46M
8.10%76.21M
-15.28%71.74M
4.68%71.03M
-2.54%64.48M
4.14%70.50M
-19.85%84.69M
-45.87%67.85M
-79.34%66.17M
-73.10%67.70M
-53.63%105.66M
-18.41%125.34M
-10.90%320.27M
-14.68%251.67M
124.02%227.87M
Operating profit
-71.97%-33.90M
-74.90%-34.62M
-124.59%-36.24M
10.12%-15.35M
-4.27%-19.71M
9.19%-19.80M
47.76%-16.14M
-8080.84%-17.08M
4.51%-18.91M
12.19%-21.80M
15.56%-30.89M
-53.17%214.00K
-226.18%-19.80M
-112.29%-24.82M
-124.25%-36.58M
-99.71%457.00K
-84.14%15.69M
-24.35%201.93M
-33.22%150.86M
150.73%159.27M
Net Profit
-55.77%-29.53M
-115.32%-24.83M
-297.72%-23.42M
54.89%-6.61M
-117.65%-18.96M
14.35%-11.53M
95.41%-5.89M
-11.76%-14.65M
22.43%-8.71M
12.24%-13.46M
-437.72%-128.15M
-862.48%-13.11M
-197.33%-11.23M
-109.96%-15.34M
-122.84%-23.83M
-98.60%1.72M
-85.54%11.54M
-23.28%153.98M
-37.26%104.34M
162.71%122.52M
Balance Sheet
Current assets
6.07%454.77M
14.94%479.04M
55.69%550.49M
55.38%507.37M
7.42%428.73M
7.83%416.78M
-30.38%353.57M
-40.61%326.54M
-24.45%399.10M
-33.44%386.51M
-19.12%507.85M
-21.07%549.86M
-21.76%528.29M
-24.12%580.72M
2.60%627.87M
11.85%696.61M
19.15%675.18M
16.11%765.33M
16.87%611.96M
218.40%622.84M
Total current liabilities
0.59%71.76M
36.74%90.13M
16.55%84.97M
-2.11%72.43M
-5.83%71.33M
-13.21%65.92M
-0.16%72.90M
20.46%73.99M
16.87%75.75M
-7.31%75.95M
-17.13%73.02M
-40.09%61.42M
-49.17%64.82M
-42.18%81.94M
-16.34%88.11M
-30.33%102.52M
4.94%127.53M
-27.89%141.71M
-19.06%105.31M
154.88%147.16M
Total assets
-9.22%1.09B
-4.09%1.16B
-0.53%1.21B
-1.56%1.21B
-2.63%1.20B
-1.96%1.21B
-1.24%1.22B
-9.18%1.23B
-9.03%1.23B
-10.67%1.23B
-10.87%1.24B
-3.37%1.36B
-7.33%1.35B
-6.06%1.38B
8.39%1.39B
16.69%1.41B
39.23%1.46B
46.69%1.47B
82.55%1.28B
387.11%1.20B
Total liabilities
5.71%93.24M
35.24%112.22M
17.63%106.81M
-5.12%93.81M
-14.69%88.20M
-19.63%82.97M
-11.01%90.81M
2.38%98.86M
13.30%103.39M
-4.27%103.24M
-12.17%102.04M
-22.37%96.56M
-39.54%91.25M
-29.34%107.85M
2.96%116.18M
-22.36%124.39M
16.88%150.93M
-22.73%152.63M
-13.91%112.84M
165.45%160.22M
Total equity
-10.40%995.99M
-7.00%1.04B
-1.99%1.11B
-1.25%1.12B
-1.52%1.11B
-0.34%1.12B
-0.36%1.13B
-10.06%1.13B
-10.64%1.13B
-11.21%1.13B
-10.76%1.13B
-1.53%1.26B
-3.62%1.26B
-3.35%1.27B
8.92%1.27B
22.69%1.28B
42.36%1.31B
63.80%1.31B
104.76%1.17B
458.67%1.04B
Cash Flow Statement
Net operating income
21.26%-23.76M
260.17%7.10M
-412.35%-78.14M
171.62%11.11M
-804.11%-30.17M
-160.98%-4.43M
67.53%25.02M
-251.46%-15.51M
-55.99%4.29M
191.89%7.27M
-55.03%14.93M
-50.71%10.24M
-12.48%9.74M
-104.20%-7.91M
-56.92%33.21M
-86.35%20.78M
-85.38%11.13M
-19.20%188.41M
-42.58%77.09M
1516.58%152.20M
Net investment
-4.87%50.80M
-60.55%10.94M
140.63%11.15M
112.40%19.08M
631.16%53.40M
158.77%27.73M
-213.12%-27.45M
-55.25%8.98M
766.42%7.30M
-983.74%-47.19M
126.21%24.27M
-54.67%20.08M
99.49%-1.10M
-732.85%-4.35M
33.98%-92.60M
227.29%44.29M
-37.86%-213.69M
100.32%688.00K
56.00%-140.26M
-2378.13%-34.79M
Net financing
-818.31%-24.23M
-301.30%-44.83M
-63.30%-534.00K
21.52%-445.00K
-130.19%-2.64M
-298.00%-11.17M
98.74%-327.00K
87.33%-567.00K
92.95%-1.15M
-154.95%-2.81M
12.31%-25.95M
87.38%-4.47M
-45.79%-16.26M
-17.88%-1.10M
-324.97%-29.59M
-1086.42%-35.46M
-139.98%-11.15M
-101.97%-934.00K
-93.99%13.15M
-107.02%-2.99M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Fulgent Genetics Inc?

According to Fulgent Genetics Inc's FY2025 earnings report, its total revenue reached 322.67M, with a year-on-year change of 283.47M.

What are the current assets of Fulgent Genetics Inc?

According to Fulgent Genetics Inc's FY2025 earnings report, its current assets were 550.49M, with a year-on-year change of 55.69.

What are the total assets of Fulgent Genetics Inc?

According to Fulgent Genetics Inc's FY2025 earnings report, its total assets of Fulgent Genetics Inc were 1.21B, with a year-on-year change of -0.53.

What are the total liabilities of Fulgent Genetics Inc?

According to Fulgent Genetics Inc's FY2025 earnings report, its total liabilities of Fulgent Genetics Inc were 106.81M, with a year-on-year change of 17.63.

What is the total equity of Fulgent Genetics Inc?

According to Fulgent Genetics Inc's FY2025 earnings report, its total equity of Fulgent Genetics Inc was 1.11B, with a year-on-year change of -1.99.

What is the net operating income of Fulgent Genetics Inc?

According to Fulgent Genetics Inc's FY2025 earnings report, its net operating income of Fulgent Genetics Inc was -91.10M, with a year-on-year change of -23.24.

What is the net investment of Fulgent Genetics Inc?

According to Fulgent Genetics Inc's FY2025 earnings report, its net investment of Fulgent Genetics Inc was 111.37M, with a year-on-year change of 290.86.

What is the net financing of Fulgent Genetics Inc?

According to Fulgent Genetics Inc's FY2025 earnings report, its net financing of Fulgent Genetics Inc was -14.79M, with a year-on-year change of -205.12.

What is the Earnings Per Share (EPS) of Fulgent Genetics Inc?

According to Fulgent Genetics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.97, with a year-on-year change of -39.19.

What is the net income of Fulgent Genetics Inc?

According to Fulgent Genetics Inc's FY2025 earnings report, its net income was -60.51M, with a year-on-year change of -41.69.

What is the net margin of Fulgent Genetics Inc?

According to Fulgent Genetics Inc's FY2025 earnings report, its net profit margin was -19.10, with a year-on-year change of -23.56.

What is the gross margin of Fulgent Genetics Inc?

According to Fulgent Genetics Inc's FY2025 earnings report, its gross margin was 38.07, with a year-on-year change of 8.74.

What is the debt-to-asset ratio of Fulgent Genetics Inc?

According to Fulgent Genetics Inc's FY2025 earnings report, its debt-to-asset ratio was 0.23, with a year-on-year change of -23.32.

What is the Return on Equity (ROE) of Fulgent Genetics Inc?

According to Fulgent Genetics Inc's FY2025 earnings report, its Return on Equity (ROE) was -5.39, with a year-on-year change of -43.21.

What is the Return on Assets (ROA) of Fulgent Genetics Inc?

According to Fulgent Genetics Inc's FY2025 earnings report, its Return on Assets (ROA) was -5.07, with a year-on-year change of -41.91.

What is the operating profit of Fulgent Genetics Inc?

According to Fulgent Genetics Inc's FY2025 earnings report, its operating profit was -91.10M, with a year-on-year change of -23.24.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy